SRXN1 and cervical carcinoma: Then, we confirmed that the Wnt/β-catenin pathway was stimulated by Srx in HeLa, SiHa and C33A cells, with activation of CD44—its target genes—resulting in the promotion of invasion and migration in cervical cancer cell lines.